We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pharma partners with efforts to pool patient genotype and phenotype data.
- Authors
Ratner, Mark
- Abstract
The article reports that the announcement of partnership between Pfizer Inc. and 23 & Me Inc. in August 2014 has cleared up the value of biopharma companies which are starting to attach to combining genomics with a range of patient-derived phenotypic data. The move boost for the direct-to-consumer business models of for-profit firms like 23 & Me and PatientsLikeMe. It is also in lockstep with government-driven initiatives.
- Subjects
PFIZER Inc.; 23 &; Me Inc.; BUSINESS partnerships; BIOPHARMACEUTICS; PATIENTSLIKEME (Company); GENOMICS
- Publication
Nature Biotechnology, 2014, Vol 32, Issue 10, p967
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt1014-967